Hospital Acquired Infections Therapeutic Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Antibacterial Drugs {Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, Others}, Antiviral Drugs, Antifungal Drugs); By Infection Type; By Regions; Segment Forecast, 2021 - 2028

报告摘要

全球医院收购的感染治疗市场在2020年的104.5亿美元上价值，预计预测期间的CAGR 2.3％。负责医院收购感染治疗性市场增长的关键因素包括增加医院收购感染的患病率，新药疗法的批准在过去十年中含有这种疾病和传染病的激增。

了解有关此报告的更多信息：request for sample pages

Nosocomial illnesses are also known as hospital acquired infections (HAI) are mostly caused by viral, fungal, and bacteria pathogens during surgeries or medical treatment in healthcare facilities. Most common infection includes surgical site, ventilator-associated, urinary tract, and bloodstream illnesses. Increasing prevalence and lack of justified data significantly pushing the demand for hospital acquired infections therapeutic market.

根据经济合作和发展组织（经合组织）所做的研究，2018年，欧洲联盟中有约380万人被​​医院诊断为急性护理设施中的疾病。此外，经合组织还估计，每年欧洲约有90,000人死于医院获得的感染。

然而，在新兴国家，医院患有几种致死类型感染的发生率逐渐下降。据疾病疾病疾病委员会发表的报告称，2018年，医院在美国急性护理医院的感染率下降，据报道，血流感染的下降9％，尿路感染下降8％，患有梭菌感染的下降12％。

这种下降主要是由于专用的音乐会ed effort of strict regulatory norms and awareness among medical professionals. Developed countries like Germany, France, UK, and the U.S. have specialized medical facilities and can easily adhere to the strict policy regime. Thus, the decline in the demand for hospital acquired infections therapeutics in the developed economies with strict precautionary measures might hamper the therapeutic market growth.

Hospital Acquired Infections Therapeutic Market Report Scope

该市场主要根据药物课程，感染类型和地理区域进行分段。

通过毒品课	By Infection Type	按地区
Antibacterial Drugs Cell Wall Synthesis Inhibitors Protein Synthesis Inhibitors Others Antiviral Drugs 抗真菌药物	Urinary Tract Infections Ventilator-associated Pneumonia 手术部位 Bloodstream Other Hospital	北美（美国，加拿大） 欧洲（法国，德国，英国，意大利，西班牙，荷兰，奥地利） Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) 拉丁美洲（巴西，墨西哥，阿根廷） 中东和非洲（沙特阿拉伯，阿联酋，以色列，南非）

了解有关此报告的更多信息：request for sample pages

Insight by Infection Type

The surgical site acquired illnesses market segment accounted for the largest revenue share of the therapeutic market in 2020. This high share is attributed to the rise in the number of surgeries, increasing hospital admissions, the subsequent onset of surgical site infections.

As per the statistics published by the CDC, about 27 million surgeries are performed in a year, out of which around 5% of hospitalized patients have developed surgical site infections. Each year around 300,000 patients in the country are affected by such infections. SSIs also increases the length of hospital stay from 7 to 11 days and are expected to cost around USD 3,000.

但是，在医院获得的尿路感染（UTI）预计将在评估期内见证最高增长率。越来越大的患者对新兴国家条件的认识以及utis的上升案例。UTIS在女性中更常见，其中大约40％的人在生活中的某个时间经历了UTIS的情况。此外，推出新药遏制utis也有利于细分分部的疗养增长前景。

Insight by Drug Class

2020年，抗菌药物市场分部占治疗市场的最大收入份额。这些优势归因于，由于该部门的起源和研究和创新，所以医院的大多数被收购的感染的事实归因于该部门的研究和创新。因此，用这种抗菌药物治疗了大部分医院所获得的感染。

Moreover, anti-bacterial therapeutics is regarded as the gold standard in treating hospital acquired infections. Multidrug-resistant micro-organisms should be treated with broad-spectrum antibiotics with minimal complications. Ideal anti-bacterial therapy should be short as 7 days, in comparison to 14 to 21 days.

Geographic Overview

在地理上，地理位置上，全球医院患有感染治疗性的市场分叉进入北美，欧洲，亚太地区，拉丁美洲和中东和非洲（MEA）。欧洲市场是最大的收入贡献者，其次是北美和亚太地区。

In 2020, the Europe market accounted for over 30% of the global market for therapeutics. Regional factors responsible for such growth include the high prevalence of hospital acquired infections in the region, the strong pipeline of therapeutic drugs, and increased commercial activities in the industry. Moreover, the presence of industry giants in the region also supported the market growth.

竞争洞察力

杰出的参与者在医院收购感染市场上运营的突出球员是Merck，Abbott Laboratories，Pfizer Inc.，Glaxosmithkline Plc。，Bayer Ag，Abbvie Inc.，F. Hoffmann-La Roche Ltd，Daiichi Sankyo Company，Limited和Allergan Plc。市场上的公司正在推动市场上的新产品采用增长策略;通过兼并和收购和联合企业;并通过进入新的地理领土。